Reducing Hereditary Cancer Act of 2021
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jun 23, 2021)
Reducing Hereditary Cancer Act of 2021
This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
What just happenedJun 24, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJun 23, 2021
- Jun 24, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jun 23, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jun 23, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Jun 23, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jun 23, 2021IntroReferralIntro-H
Introduced in House
- Jun 23, 2021IntroReferral1000
Introduced in House